Currently, Sexually Transmitted Diseases (STDs) are reaching record highs in Europe.
According to data from the ECDC (European Centre for Disease Prevention and Control), there has been:
- A 303% increase in gonorrhea since 2015;
- A doubling of syphilis cases since 2015;
- Approximately 213,000 cases of chlamydia in 2024, making it the most prevalent STI.
You can read the full article HERE.
Therefore, investing in testing means protecting sexual and reproductive health. At IMP Diagnostics, we believe that rapid, accessible, and reliable diagnostic solutions are essential for strengthening prevention, improving clinical response, and supporting public health.